Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.

circulating tumor cells glycolysis menin menin-associated proteins oxidative phosphorylation

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
22 Sep 2020
Historique:
received: 17 07 2020
revised: 04 09 2020
accepted: 08 09 2020
entrez: 25 9 2020
pubmed: 26 9 2020
medline: 26 9 2020
Statut: epublish

Résumé

The interplay between glycolysis and mitochondrial oxidative phosphorylation (OXPHOS) is central to maintain energy homeostasis. It remains to be determined whether there is a mechanism governing metabolic fluxes based on substrate availability in microenvironments. Here we show that menin is a key transcription factor regulating the expression of OXPHOS and glycolytic genes in cancer cells and primary tumors with poor prognosis. A group of menin-associated proteins (MAPs), including KMT2A, MED12, WAPL, and GATA3, is found to restrain menin's full function in this transcription regulation. shRNA knockdowns of menin and MAPs result in reduced ATP production with proportional alterations of cellular energy generated through glycolysis and OXPHOS. When shRNA knockdown cells are exposed to metabolic stress, the dual functionality can clearly be distinguished among these metabolic regulators. A MAP can negatively counteract the regulatory mode of menin for OXPHOS while the same protein positively influences glycolysis. A close-proximity interaction between menin and MAPs allows transcriptional regulation for metabolic adjustment. This coordinate regulation by menin and MAPs is necessary for cells to rapidly adapt to fluctuating microenvironments and to maintain essential metabolic functions.

Identifiants

pubmed: 32971831
pii: cancers12092715
doi: 10.3390/cancers12092715
pmc: PMC7564175
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM137009
Pays : United States
Organisme : NCI NIH HHS
ID : U54CA217297, P30CA054174
Pays : United States
Organisme : NCI NIH HHS
ID : U54 CA217297
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA054174
Pays : United States
Organisme : Cancer Prevention and Research Institute of Texas
ID : RP150600, RR160017

Références

Nat Rev Mol Cell Biol. 2016 Apr;17(4):213-26
pubmed: 26956194
J Clin Endocrinol Metab. 2012 Sep;97(9):2990-3011
pubmed: 22723327
Nature. 2012 Feb 12;482(7386):542-6
pubmed: 22327296
Mol Cell Biol. 2004 Jul;24(13):5639-49
pubmed: 15199122
Prostate. 2013 Jun;73(8):813-26
pubmed: 23280481
Science. 2016 Oct 28;354(6311):
pubmed: 27789812
Nat Commun. 2020 Feb 21;11(1):1009
pubmed: 32081882
J Biol Chem. 2011 Sep 9;286(36):31742-8
pubmed: 21757704
Mol Cell Biol. 2009 Oct;29(20):5477-87
pubmed: 19651895
Trends Biochem Sci. 2013 Aug;38(8):394-402
pubmed: 23850066
Nat Cell Biol. 2014 Oct;16(10):992-1003, 1-15
pubmed: 25241037
Nat Rev Cancer. 2007 Nov;7(11):823-33
pubmed: 17957188
Cancer Cell. 2018 Mar 12;33(3):368-385.e7
pubmed: 29455928
PLoS One. 2010 Apr 01;5(4):e9985
pubmed: 20376309
Nat Rev Mol Cell Biol. 2019 Jul;20(7):436-450
pubmed: 30976106
BMC Genomics. 2008 Jan 14;9:18
pubmed: 18194548
Gene Expr. 2017 Jul 7;17(3):251-263
pubmed: 28485270
Cell Metab. 2016 Mar 8;23(3):517-28
pubmed: 26853747
Cancers (Basel). 2012 Sep 10;4(3):904-44
pubmed: 24213472
Endocr Relat Cancer. 2017 Oct;24(10):T147-T159
pubmed: 28811300
Cancer Res. 2003 Jul 15;63(14):4204-10
pubmed: 12874027
Trends Biochem Sci. 2016 Mar;41(3):211-218
pubmed: 26778478
Essays Biochem. 2018 Jul 20;62(3):255-270
pubmed: 30030361
Cancer Cell. 2015 Apr 13;27(4):589-602
pubmed: 25817203
Endocr Relat Cancer. 2017 Oct;24(10):T135-T145
pubmed: 28811299
Cancer Res. 2006 May 1;66(9):4929-35
pubmed: 16651450
Proc Natl Acad Sci U S A. 2001 Mar 27;98(7):3837-42
pubmed: 11274402
Mol Cell. 2019 Aug 22;75(4):791-806.e8
pubmed: 31303470
Mol Cancer Ther. 2019 Feb;18(2):437-447
pubmed: 30401696
Biochim Biophys Acta. 2007 Dec;1773(12):1701-20
pubmed: 18240421
Nat Med. 2015 Apr;21(4):344-52
pubmed: 25822367
Cell. 2017 Mar 9;168(6):960-976
pubmed: 28283069
N Engl J Med. 2014 Aug 7;371(6):583-4
pubmed: 25099597
Mol Cancer Res. 2017 May;15(5):553-562
pubmed: 28130400
Methods Enzymol. 2014;547:309-54
pubmed: 25416364
Oncogene. 2001 Aug 16;20(36):4917-25
pubmed: 11526476
Proteomics. 2016 Oct;16(19):2503-2518
pubmed: 27329485
Cells. 2018 Mar 02;7(3):
pubmed: 29498679
Biochimie. 2011 Apr;93(4):697-709
pubmed: 21195125
Nat Commun. 2017 May 05;8:15278
pubmed: 28474697
Ocul Surf. 2018 Jul;16(3):341-351
pubmed: 29709661
Cells. 2019 Jun 29;8(7):
pubmed: 31261917
Cell Rep. 2017 Mar 7;18(10):2359-2372
pubmed: 28273452
Cell. 2005 Oct 21;123(2):207-18
pubmed: 16239140
J Hepatol. 2013 Dec;59(6):1299-306
pubmed: 23867312
Exp Cell Res. 2017 Jul 15;356(2):182-186
pubmed: 28286304
Proc Natl Acad Sci U S A. 2019 Feb 26;116(9):3909-3918
pubmed: 30733294
Cancer Res. 2017 Apr 1;77(7):1564-1574
pubmed: 28202516

Auteurs

Chih-Wei Chou (CW)

Department of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.

Xi Tan (X)

Department of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.

Chia-Nung Hung (CN)

Department of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.
Department of Life Science, Tunghai University, Taichung 407, Taiwan.

Brandon Lieberman (B)

Department of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.

Meizhen Chen (M)

Department of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.

Meena Kusi (M)

Department of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.

Kohzoh Mitsuya (K)

Department of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.

Chun-Lin Lin (CL)

Department of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.

Masahiro Morita (M)

Department of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.

Zhijie Liu (Z)

Department of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.

Chun-Liang Chen (CL)

Department of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.

Tim Hui-Ming Huang (TH)

Department of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.

Classifications MeSH